Instrument Inactif

Autres langues Furiex Pharmaceuticals Inc

Actions

US36106P1012

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

2014	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue	RE
2014	Actavis : Forest Laboratories achète Furiex pour 1,46 milliard de dollars	RE

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Furiex Pharmaceuticals : Actavis Completes Acquisition of Furiex Pharmaceuticals	02/07/14
Furiex Pharmaceuticals : Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger	01/07/14
Furiex Pharmaceuticals : Reports First Quarter 2014 Financial Results	07/05/14
Actavis : Factbox - M&A frenzy transforming global pharma	06/05/14
Actavis : M&A frenzy in healthcare sector	06/05/14
Furiex Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Furiex Pharmaceuticals, Inc.	29/04/14
Furiex Pharmaceuticals : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Furiex Pharmaceuticals, Inc. Stockholders	29/04/14
Furiex Pharmaceuticals : Stockholders Encouraged to Contact Securities Law Firm about Takeover	28/04/14
Furiex Pharmaceuticals : Newman Ferrara LLP : Announces Investigation of Furiex Pharmaceuticals, Inc.	28/04/14
Furiex Pharmaceuticals : Announces First Quarter 2014 Earnings Release and Conference Call	07/04/14
Furiex Pharmaceuticals : Announces Acceptance to Late-Breaking Abstract Session at Digestive Disease Week 2014	03/04/14
Furiex Pharmaceuticals : Confirms Takeda Will Present Additional Data from the EXAMINE Trial at the American College of Cardiology's 63rd Annual Scientific Session	27/03/14
Furiex Pharmaceuticals : Confirms Takeda Will Present Additional Data from the EXAMINE Trial at the American College of Cardiology’s 63rd Annual Scientific Session	27/03/14
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Reports Fourth Quarter and Full-Year 2013 Financial Results	11/03/14
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Confirms Takeda's Submission of a New Drug Application for Trelagliptin Succinate (SYR-472) in Japan for the Treatment of Type 2 Diabetes	07/03/14
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Fourth Quarter 2013 Earnings Release and Conference Call	10/02/14
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Positive Top-Line Results of Two Pivotal Phase III Clinical Trials of Eluxadoline in Patients with IBS-d	04/02/14
Furiex Pharmaceuticals Inc : Furiex Reports Third Quarter 2013 Financial Results	05/11/13
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Priligy® Launch in the United Kingdom by Menarini	31/10/13
Furiex Pharmaceuticals Inc : Furiex Pharmaceuticals Announces Management Changes	28/10/13

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Furiex Pharmaceuticals Inc

Actions

US36106P1012

Autres langues

Filtres